Global Allergy Immunotherapies Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031

TABLE OF CONTENTS

1 Study Coverage

• 1.1 Allergy Immunotherapies Product Introduction
• 1.2 Market by Type
  • 1.2.1 Global Allergy Immunotherapies Market Size Growth Rate by Type (2020 VS 2024 VS 2031)
  • 1.2.2 Subcutaneous Immunotherapy
  • 1.2.3 Sublingual Immunotherapy
• 1.3 Market by Application
  • 1.3.1 Global Allergy Immunotherapies Market Size Growth Rate by Application (2020 VS 2024 VS 2031)
  • 1.3.2 Allergic Rhinitis
  • 1.3.3 Allergic Asthma
  • 1.3.4 Other
• 1.4 Assumptions and Limitations
• 1.5 Study Objectives
• 1.6 Years Considered

2 Executive Summary

• 2.1 Global Allergy Immunotherapies Market Size Estimates and Forecasts
• 2.2 Allergy Immunotherapies Market Size by Region: 2024 Versus 2031
  • 2.2.1 Global Allergy Immunotherapies Revenue by Region: 2020-2025
  • 2.2.2 Global Allergy Immunotherapies Revenue Forecast by Region (2026-2031)
  • 2.2.3 Global Allergy Immunotherapies Revenue Market Share by Region (2020-2031)

3 Market Segments

• 3.1 Breakdown Data by Type
  • 3.1.1 Global Allergy Immunotherapies Revenue by Type (2020-2031)
  • 3.1.2 Global Allergy Immunotherapies Revenue Market Share by Type (2020-2031)
• 3.2 Breakdown Data by Application
  • 3.2.1 Global Allergy Immunotherapies Revenue by Application (2020-2031)
  • 3.2.2 Global Allergy Immunotherapies Revenue Market Share by Application (2020-2031)
• 3.3 by Type and by Application Crossing Analysis
  • 3.3.1 Subcutaneous Immunotherapy of Allergy Immunotherapies Revenue Market Share by Application
  • 3.3.2 Sublingual Immunotherapy of Allergy Immunotherapies Revenue Market Share by Application

4 Global Allergy Immunotherapies by Company

• 4.1 Global Allergy Immunotherapies Revenue by Company (2020-2025)
• 4.2 Global Allergy Immunotherapies Revenue Share by Company (2020-2025)
• 4.3 Competitive Landscape
  • 4.3.1 Key Allergy Immunotherapies Companies around the World: Ranking by Revenue
  • 4.3.2 Global Allergy Immunotherapies Market Concentration Ratio (CR5 and HHI) & (2020-2025)
  • 4.3.3 Global Allergy Immunotherapies Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
• 4.4 Global Allergy Immunotherapies Companies Headquarters & Product Type
  • 4.4.1 Global Allergy Immunotherapies Companies Headquarters
  • 4.4.2 Date of International Companies Enter into Allergy Immunotherapies Market
  • 4.4.3 Global Allergy Immunotherapies Companies Product & Service
  • 4.4.4 Subcutaneous Immunotherapy Revenue Market Share of Allergy Immunotherapies by Company
  • 4.4.5 Sublingual Immunotherapy Revenue Market Share of Allergy Immunotherapies by Company
• 4.5 Global Allergy Immunotherapies Mergers & Acquisitions, Expansion Plans

5 Company Profiles

• 5.1 ALK
  • 5.1.1 ALK Corporation Information
  • 5.1.2 ALK Description, Business Overview
  • 5.1.3 ALK Allergy Immunotherapies Products Offered
  • 5.1.4 ALK Allergy Immunotherapies Revenue and Gross Margin (2020-2025)
  • 5.1.5 ALK Allergy Immunotherapies Revenue by Product in 2024
  • 5.1.6 ALK Allergy Immunotherapies Revenue by Application in 2024
  • 5.1.7 ALK Allergy Immunotherapies Revenue by Geographic Area in 2024
  • 5.1.8 ALK Recent Developments
• 5.2 Stallergenes
  • 5.2.1 Stallergenes Corporation Information
  • 5.2.2 Stallergenes Description, Business Overview
  • 5.2.3 Stallergenes Allergy Immunotherapies Products Offered
  • 5.2.4 Stallergenes Allergy Immunotherapies Revenue and Gross Margin (2020-2025)
  • 5.2.5 Stallergenes Allergy Immunotherapies Revenue by Product in 2024
  • 5.2.6 Stallergenes Allergy Immunotherapies Revenue by Application in 2024
  • 5.2.7 Stallergenes Allergy Immunotherapies Revenue by Geographic Area in 2024
  • 5.2.8 Stallergenes Recent Developments
• 5.3 HAL
  • 5.3.1 HAL Corporation Information
  • 5.3.2 HAL Description, Business Overview
  • 5.3.3 HAL Allergy Immunotherapies Products Offered
  • 5.3.4 HAL Allergy Immunotherapies Revenue and Gross Margin (2020-2025)
  • 5.3.5 HAL Allergy Immunotherapies Revenue by Product in 2024
  • 5.3.6 HAL Allergy Immunotherapies Revenue by Application in 2024
  • 5.3.7 HAL Allergy Immunotherapies Revenue by Geographic Area in 2024
  • 5.3.8 HAL Recent Developments

6 North America

• 6.1 North America Allergy Immunotherapies Market Size YoY Growth 2020-2031
• 6.2 North America Allergy Immunotherapies Market Facts & Figures by Country (2020-2031)
• 6.3 North America Allergy Immunotherapies Revenue by Type (2020-2025)
• 6.4 North America Allergy Immunotherapies Revenue by Application (2020-2025)

7 Asia-Pacific

• 7.1 Asia-Pacific Allergy Immunotherapies Market Size YoY Growth 2020-2031
• 7.2 Asia-Pacific Allergy Immunotherapies Market Facts & Figures by Region (2020-2031)
• 7.3 Asia-Pacific Allergy Immunotherapies Revenue by Type (2020-2025)
• 7.4 Asia-Pacific Allergy Immunotherapies Revenue by Application (2020-2025)

8 Europe

• 8.1 Europe Allergy Immunotherapies Market Size YoY Growth 2020-2031
• 8.2 Europe Allergy Immunotherapies Market Facts & Figures by Country (2020-2031)
• 8.3 Europe Allergy Immunotherapies Revenue by Type (2020-2025)
• 8.4 Europe Allergy Immunotherapies Revenue by Application (2020-2025)

9 Latin America

• 9.1 Latin America Allergy Immunotherapies Market Size YoY Growth 2020-2031
• 9.2 Latin America Allergy Immunotherapies Market Facts & Figures by Country (2020-2031)
• 9.3 Latin America Allergy Immunotherapies Revenue by Type (2020-2025)
• 9.4 Latin America Allergy Immunotherapies Revenue by Application (2020-2025)

10 Middle East and Africa

• 10.1 Latin America Allergy Immunotherapies Market Size YoY Growth 2020-2031
• 10.2 Middle East and Africa Allergy Immunotherapies Market Facts & Figures by Country (2020-2031)
• 10.3 Middle East and Africa Allergy Immunotherapies Revenue by Type (2020-2025)
• 10.4 Middle East and Africa Allergy Immunotherapies Revenue by Application (2020-2025)

11 Supply Chain and Sales Channel analysis

• 11.1 Allergy Immunotherapies Supply Chain Analysis
• 11.2 Allergy Immunotherapies Key Raw Materials and Upstream Suppliers
• 11.3 Allergy Immunotherapies Clients Analysis
• 11.4 Allergy Immunotherapies Sales Channel and Sales Model Analysis
  • 11.4.1 Allergy Immunotherapies Distribution Channel Analysis: Indirect Sales VS Direct Sales
  • 11.4.2 Allergy Immunotherapies Distribution Channel Analysis: Online Sales VS Offline Sales
  • 11.4.3 Allergy Immunotherapies Distributors

12 Allergy Immunotherapies Market Dynamics

• 12.1 Allergy Immunotherapies Industry Trends
• 12.2 Allergy Immunotherapies Market Drivers
• 12.3 Allergy Immunotherapies Market Challenges
• 12.4 Allergy Immunotherapies Market Restraints

13 Research Findings and Conclusion

14 Appendix

• 14.1 Research Methodology
  • 14.1.1 Methodology/Research Approach
    • 14.1.1.1 Research Programs/Design
    • 14.1.1.2 Market Size Estimation
    • 14.1.1.3 Market Breakdown and Data Triangulation
  • 14.1.2 Data Source
    • 14.1.2.1 Secondary Sources
    • 14.1.2.2 Primary Sources
• 14.2 Author Details
• 14.3 Disclaimer

List of Tables

Table 1. Global Allergy Immunotherapies Market Size Growth Rate (CAGR) by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Global Allergy Immunotherapies Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 3. Global Allergy Immunotherapies Market Size by Region (US$ Million): 2024 VS 2031

Table 4. Global Allergy Immunotherapies Revenue by Region (2020-2025) & (US$ Million)

Table 5. Global Allergy Immunotherapies Revenue Forecast by Region (2026-2031) & (US$ Million)

Table 6. Global Allergy Immunotherapies Revenue by Type (2020-2025) & (US$ Million)

Table 7. Global Allergy Immunotherapies Revenue Forecast by Type (2026-2031) & (US$ Million)

Table 8. Global Allergy Immunotherapies Revenue by Application (2020-2025) & (US$ Million)

Table 9. Global Allergy Immunotherapies Revenue Forecast by Application (2026-2031) & (US$ Million)

Table 10. Allergy Immunotherapies Revenue by Company (2020-2025) & (US$ Million)

Table 11. Allergy Immunotherapies Revenue Share by Company (2020-2025)

Table 12. Ranking of Global Top Allergy Immunotherapies Players by Revenue (US$ Million) in 2024

Table 13. Global Allergy Immunotherapies Companies Market Concentration Ratio (CR5 and HHI) & (2020-2025)

Table 14. Global Allergy Immunotherapies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Allergy Immunotherapies as of 2024)

Table 15. Global Allergy Immunotherapies Companies Headquarters

Table 16. Date of International Companies Enter into Allergy Immunotherapies Market

Table 17. Global Allergy Immunotherapies Companies Product & Service

Table 18. Global Allergy Immunotherapies Mergers & Acquisitions, Expansion Plans

Table 19. ALK Corporation Information

Table 20. ALK Description and Business Overview

Table 21. ALK Allergy Immunotherapies Product

Table 22. ALK Allergy Immunotherapies Revenue (US$ Million) and Gross Margin (2020-2025)

Table 23. ALK Revenue Proportion of Allergy Immunotherapies by Product in 2024

Table 24. ALK Revenue Proportion of Allergy Immunotherapies by Application in 2024

Table 25. ALK Revenue Proportion of Allergy Immunotherapies by Geographic Area in 2024

Table 26. ALK Recent Developments

Table 27. Stallergenes Corporation Information

Table 28. Stallergenes Description and Business Overview

Table 29. Stallergenes Allergy Immunotherapies Product

Table 30. Stallergenes Allergy Immunotherapies Revenue (US$ Million) and Gross Margin (2020-2025)

Table 31. Stallergenes Revenue Proportion of Allergy Immunotherapies by Product in 2024

Table 32. Stallergenes Revenue Proportion of Allergy Immunotherapies by Application in 2024

Table 33. Stallergenes Revenue Proportion of Allergy Immunotherapies by Geographic Area in 2024

Table 34. Stallergenes Recent Developments

Table 35. HAL Corporation Information

Table 36. HAL Description and Business Overview

Table 37. HAL Allergy Immunotherapies Product

Table 38. HAL Allergy Immunotherapies Revenue (US$ Million) and Gross Margin (2020-2025)

Table 39. HAL Revenue Proportion of Allergy Immunotherapies by Product in 2024

Table 40. HAL Revenue Proportion of Allergy Immunotherapies by Application in 2024

Table 41. HAL Revenue Proportion of Allergy Immunotherapies by Geographic Area in 2024

Table 42. HAL Recent Developments

Table 43. North America Allergy Immunotherapies Revenue by Country (2020-2025) & (US$ Million)

Table 44. North America Allergy Immunotherapies Revenue by Country (2026-2031) & (US$ Million)

Table 45. North America Allergy Immunotherapies Revenue by Type (2020-2025) & (US$ Million)

Table 46. North America Allergy Immunotherapies Revenue by Application (2020-2025) & (US$ Million)

Table 47. Asia-Pacific Allergy Immunotherapies Revenue by Region (2020-2025) & (US$ Million)

Table 48. Asia-Pacific Allergy Immunotherapies Revenue by Region (2026-2031) & (US$ Million)

Table 49. Asia-Pacific Allergy Immunotherapies Revenue by Type (2020-2025) & (US$ Million)

Table 50. Asia-Pacific Allergy Immunotherapies Revenue by Application (2020-2025) & (US$ Million)

Table 51. Europe Allergy Immunotherapies Revenue by Country (2020-2025) & (US$ Million)

Table 52. Europe Allergy Immunotherapies Revenue by Country (2026-2031) & (US$ Million)

Table 53. Europe Allergy Immunotherapies Revenue by Type (2020-2025) & (US$ Million)

Table 54. Europe Allergy Immunotherapies Revenue by Application (2020-2025) & (US$ Million)

Table 55. Latin America Allergy Immunotherapies Revenue by Country (2020-2025) & (US$ Million)

Table 56. Latin America Allergy Immunotherapies Revenue by Country (2026-2031) & (US$ Million)

Table 57. Latin America Allergy Immunotherapies Revenue by Type (2020-2025) & (US$ Million)

Table 58. Latin America Allergy Immunotherapies Revenue by Application (2020-2025) & (US$ Million)

Table 59. Middle East and Africa Allergy Immunotherapies Revenue by Country (2020-2025) & (US$ Million)

Table 60. Middle East and Africa Allergy Immunotherapies Revenue by Country (2026-2031) & (US$ Million)

Table 61. Middle East and Africa Allergy Immunotherapies Revenue by Type (2020-2025) & (US$ Million)

Table 62. Middle East and Africa Allergy Immunotherapies Revenue by Application (2020-2025) & (US$ Million)

Table 63. Allergy Immunotherapies Key Raw Materials, Industry Status and Trend

Table 64. Allergy Immunotherapies Key Raw Materials and Upstream Suppliers

Table 65. Allergy Immunotherapies Clients Status and Trend

Table 66. Allergy Immunotherapies Typical Clients

Table 67. Allergy Immunotherapies Distributors

Table 68. Allergy Immunotherapies Market Trends

Table 69. Allergy Immunotherapies Market Drivers

Table 70. Allergy Immunotherapies Market Challenges

Table 71. Allergy Immunotherapies Market Restraints

Table 72. Research Programs/Design for This Report

Table 73. Key Data Information from Secondary Sources

Table 74. Key Data Information from Primary Sources

List of Figures

Figure 1. Allergy Immunotherapies Product Picture

Figure 2. Global Allergy Immunotherapies Market Size by Type (US$ Million): 2020 VS 2024 VS 2031

Figure 3. Global Allergy Immunotherapies Revenue Market Share by Type in 2024 & 2031

Figure 4. Subcutaneous Immunotherapy Product Picture

Figure 5. Sublingual Immunotherapy Product Picture

Figure 6. Global Allergy Immunotherapies Market Size by Application (US$ Million): 2020 VS 2024 VS 2031

Figure 7. Global Allergy Immunotherapies Revenue Market Share by Application in 2024 & 2031

Figure 8. Allergic Rhinitis

Figure 9. Allergic Asthma

Figure 10. Other

Figure 11. Allergy Immunotherapies Report Years Considered

Figure 12. Global Allergy Immunotherapies Revenue, (US$ Million), 2020 VS 2024 VS 2031

Figure 13. Global Allergy Immunotherapies Market Size (2020-2031) & (US$ Million)

Figure 14. Global Allergy Immunotherapies Market Size Market Share by Region: 2024 Versus 2031

Figure 15. Global Allergy Immunotherapies Revenue Market Share by Region (2020-2031)

Figure 16. Global Allergy Immunotherapies Revenue Market Share Forecast by Type (2020-2031)

Figure 17. Global Allergy Immunotherapies Revenue Market Share Forecast by Application (2020-2031)

Figure 18. Subcutaneous Immunotherapy of Allergy Immunotherapies Revenue Market Share by Application, 2024 VS 2031

Figure 19. Sublingual Immunotherapy of Allergy Immunotherapies Revenue Market Share by Application, 2024 VS 2031

Figure 20. Allergy Immunotherapies Revenue Share by Company (2024)

Figure 21. Allergy Immunotherapies Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 22. Subcutaneous Immunotherapy Revenue Proportion by Company in 2024

Figure 23. Sublingual Immunotherapy Revenue Proportion by Company in 2024

Figure 24. North America Allergy Immunotherapies Revenue 2020-2031 (US$ Million)

Figure 25. North America Allergy Immunotherapies Revenue Market Share by Type (2020-2025)

Figure 26. North America Allergy Immunotherapies Revenue Market Share by Application (2020-2025)

Figure 27. Asia-Pacific Allergy Immunotherapies Revenue 2020-2031 (US$ Million)

Figure 28. Asia-Pacific Allergy Immunotherapies Revenue Market Share by Region (2020-2031)

Figure 29. Asia-Pacific Allergy Immunotherapies Revenue Market Share by Type (2020-2025)

Figure 30. Asia-Pacific Allergy Immunotherapies Revenue Market Share by Application (2020-2025)

Figure 31. Europe Allergy Immunotherapies Revenue Growth Rate 2020-2031 (US$ Million)

Figure 32. Europe Allergy Immunotherapies Revenue Market Share by Country (2020-2031)

Figure 33. Europe Allergy Immunotherapies Revenue Market Share by Type (2020-2025)

Figure 34. Europe Allergy Immunotherapies Revenue Market Share by Application (2020-2025)

Figure 35. Latin America Allergy Immunotherapies Revenue Growth Rate 2020-2031 (US$ Million)

Figure 36. Latin America Allergy Immunotherapies Revenue Market Share by Country (2020-2031)

Figure 37. Latin America Allergy Immunotherapies Revenue Market Share by Type (2020-2025)

Figure 38. Latin America Allergy Immunotherapies Revenue Market Share by Application (2020-2025)

Figure 39. Middle East and Africa Allergy Immunotherapies Revenue Growth Rate 2020-2031 (US$ Million)

Figure 40. Middle East and Africa Allergy Immunotherapies Revenue Market Share by Country (2020-2031)

Figure 41. Middle East and Africa Allergy Immunotherapies Revenue Market Share by Type (2020-2025)

Figure 42. Middle East and Africa Allergy Immunotherapies Revenue Market Share by Application (2020-2025)

Figure 43. Allergy Immunotherapies Supply Chain (Upstream and Downstream Market)

Figure 44. Global Production Market Share of Allergy Immunotherapies Raw Materials by Region in 2024

Figure 45. Allergy Immunotherapies Distribution Channels

Figure 46. Global Allergy Immunotherapies Percentage 2020-2031: Indirect Sales VS Direct Sales

Figure 47. Global Allergy Immunotherapies Percentage 2020-2031: Online Sales VS Offline Sales

Figure 48. Bottom-up and Top-down Approaches for This Report

Figure 49. Data Triangulation

Figure 50. Key Executives Interviewed